Viraj Kulkarni Selected Research

Viraj Kulkarni Research Topics

4	Neoplasms (Cancer) 12/2019 - 11/2004
3	Infections 01/2020 - 09/2009
3	HIV Infections (HIV Infection) 01/2019 - 03/2011
3	Viremia 10/2013 - 09/2009
2	Vaccinia 01/2018 - 11/2014
1	COVID-19 10/2021
1	Parasitic Diseases (Parasitic Disease) 01/2020
1	Malaria 01/2020
1	Disease Progression 01/2019
1	Breakthrough Infections 01/2018
1	Rubella (German Measles) 04/2015
1	Experimental Melanoma 03/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2007
1	Genomic Instability 11/2004
1	Mouth Neoplasms (Oral Cancer) 11/2004

8	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 11/2004
6	VaccinesIBA 01/2020 - 12/2007
3	AntigensIBA 04/2015 - 09/2009
2	Proteins (Proteins, Gene)FDA Link 11/2014 - 02/2013
1	Antiviral Agents (Antivirals)IBA 10/2021
1	Malaria VaccinesIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	LipidsIBA 12/2019
1	Scavenger Receptors (Scavenger Receptor)IBA 12/2019
1	Long Noncoding RNAIBA 01/2019
1	CCR5 Receptors (CCR5 Receptor)IBA 01/2019
1	DNA VaccinesIBA 01/2018
1	Neutralizing AntibodiesIBA 01/2018
1	Immunoglobulin A (IgA)IBA 01/2017
1	Rubella VaccineIBA 04/2015
1	Peptides (Polypeptides)IBA 11/2014
1	SAIDS VaccinesIBA 11/2014
1	vaxfectinIBA 10/2013
1	Interleukin-12 (IL 12)IBA 03/2013
1	Synthetic Vaccines (Recombinant Vaccines)IBA 03/2013
1	Immunoglobulin G (IgG)IBA 02/2013
1	RNA (Ribonucleic Acid)IBA 03/2011
1	polyacrylamideIBA 11/2004

2	Immunotherapy 03/2013 - 12/2007
1	Therapeutics 03/2011